Jorey Chernett bought $1.2M of Starling Oncology (TOI)
Executed Mar 13, disclosed Mar 17, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Mar 17), the stock returned +3.0% (delay-adjusted); from the execution session (Mar 13), +5.1%. Derived: entry at the session's open, exit at the close 20 sessions later.
Jorey Chernett (10% owner) filed 25 Form 4 reports in the trailing twelve months (25 purchases, 0 sales), most often in AIRS. Across 24 priced purchase filings, the average 21-session return was +13.9% from execution and +12.6% from disclosure (delay-adjusted; derived). The largest single filing was $1.4M of STIM (1,057,400 sh across 2 lots, as filed), executed Mar 18.
Healthcare · The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→33,500 sh × $4.07
Exec May 20
Filed May 21 · 9:35 AM ET TOIPURCHASE Starling Oncology Inc $123K
30,000 sh × $4.09
Exec May 19
Filed May 20 · 12:25 PM ET TOIPURCHASE Starling Oncology Inc $158K
50,000 sh × $3.15
Exec Mar 26
Filed Mar 27 · 9:34 AM ET TOIPURCHASE Starling Oncology Inc $389K
125,000 sh × $3.11
Exec Mar 24
Filed Mar 25 · 9:33 AM ET